BRCA1/2 test results impact risk management attitudes, intentions, and uptake

Breast Cancer Research and Treatment

Volumn 124, Issue 3, 2010, Pages 755-764

  O'Neill, Suzanne C ^a   Valdimarsdottir, Heiddis B ^b,c,d   Demarco, Tiffani A ^a   Peshkin, Beth N ^a   Graves, Kristi D ^a   Brown, Karen ^b   Hurley, Karen E ^e   Isaacs, Claudine ^a   Hecker, Sharon ^a   Schwartz, Marc D ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c REYKJAVIK UNIVERSITY   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

BRCA mutation; Breast cancer; Cons; Prophylactic mastectomy; Prophylactic oophorectomy; Pros; Screening

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; OVARIECTOMY; OVARY CANCER; PATIENT ATTITUDE; PATIENT DECISION MAKING; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; RISK REDUCTION;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CHOICE BEHAVIOR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC TESTING; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; LINEAR MODELS; LOGISTIC MODELS; MASS SCREENING; MASTECTOMY; MIDDLE AGED; MUTATION; ODDS RATIO; OVARIAN NEOPLASMS; OVARIECTOMY; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 78649318715     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0881-4     Document Type: Article

References (36)

1. S Chen G Parmigiani 2007 Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 1329 1333 10.1200/JCO.2006.09.1066 17416853 (Pubitemid 46706879)
2. Breast Cancer Linkage Consortium 1999 Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 91 136 1310
3. K Metcalfe HT Lynch P Ghadirian, et al. 2004 Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2328 2335 1:CAS:528:DC%2BD2cXpsVWltbs%3D 10.1200/JCO.2004.04.033 15197194 (Pubitemid 41115389)
4. National Comprehensive Cancer Network (2009) NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. v.1.2009. http://www.nccn.org/professionals/physician-gls/PDF/genetics- screening.pdf. Accessed 27 Jan 2010
5. KL Smith ME Robson 2006 Update on hereditary breast cancer Curr Oncol Rep 8 14 21 10.1007/s11912-006-0004-x 16464398
6. ND Kauff JM Satagopan ME Robson, et al. 2002 Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 1609 1615 10.1056/NEJMoa020119 12023992 (Pubitemid 34755668)
7. TR Rebbeck HT Lynch SL Neuhausen, et al. 2002 Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 1616 1622 10.1056/NEJMoa012158 12023993 (Pubitemid 34755669)
8. GR Vink CJ van Asperen P Devilee, et al. 2005 Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines Eur J Hum Genet 13 525 527 1:CAS:528: DC%2BD2MXjsFOntrk%3D 10.1038/sj.ejhg.5201379 15741995 (Pubitemid 40691391)
9. National Comprehensive Cancer Network (2009) NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. v.1.2010. http://www.nccn.org/professionals/physician-gls/PDF/breast- screening.pdf. Accessed 27 Jan 2010
10. SM Domchek MM Gaudet JE Stopfer, et al. 2009 Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2 Breast Cancer Res Treat 119 409 414 10.1007/s10549-009-0611-y
11. LJ Herrinton WE Barlow O Yu, et al. 2005 Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project J Clin Oncol 23 4275 4286 10.1200/JCO.2005.10.080 15795415 (Pubitemid 46207002)
12. SK McDonnell DJ Schaid JL Myers, et al. 2001 Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer J Clin Oncol 19 3938 3943 1:STN:280:DC%2BD3Mrjt1Cgsg%3D%3D 11579114
13. EA Peralta JD Ellenhorn LD Wagman, et al. 2000 Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer Am J Surg 180 439 445 1:STN:280:DC%2BD3M7lvVWqsQ%3D%3D 10.1016/S0002-9610(00)00505-5 11182394 (Pubitemid 32166835)
14. M Tilanus-Linthorst L Verhoog IM Obdeijn, et al. 2002 A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography Int J Cancer 102 91 95 1:CAS:528:DC%2BD38XnvFCru7Y%3D 10.1002/ijc.10666 12353239
15. TR Rebbeck ND Kauff SM Domchek 2009 Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 80 97 1:CAS:528:DC%2BD1MXhtVehsbo%3D 10.1093/jnci/djn442 19141781
16. JB Madalinska J Hollenstein E Bleiker, et al. 2005 Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer J Clin Oncol 23 6890 6898 10.1200/JCO.2005.02.626 16129845
17. WH Parker V Jacoby D Shoupe, et al. 2009 Effect of bilateral oophorectomy on women's long-term health Womens Health (Lond Engl) 5 565 576
18. MO Verhoeven MJ van der Mooren T Teerlink, et al. 2009 The influence of physiological and surgical menopause on coronary heart disease risk markers Menopause 16 37 49 10.1097/gme.0b013e31817c42d6 18791484
19. C Rini SC O'Neill H Valdimarsdottir, et al. 2009 Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results Health Psychol 28 569 578 10.1037/a0015205 19751083
20. CY Fang SM Miller J Malick, et al. 2003 Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer Prev Med 37 424 431 10.1016/S0091-7435(03)00163-4 14572427 (Pubitemid 37321353)
21. JK Litton SN Westin K Ready, et al. 2009 Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation Cancer 115 1598 1604 10.1002/cncr.24199 19280625
22. E Warner H Messersmith P Causer, et al. 2008 Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer Ann Intern Med 148 671 679 18458280
23. MD Schwartz HB Valdimarsdottir TA DeMarco, et al. 2009 Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction Health Psychol 28 11 19 10.1037/a0013147 19210013
24. MD Schwartz BN Peshkin C Hughes, et al. 2002 Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample J Clin Oncol 20 514 520 10.1200/JCO.20.2.514 11786581 (Pubitemid 34072536)
25. MD Schwartz BN Peshkin KP Tercyak, et al. 2005 Decision making and decision support for hereditary breast-ovarian cancer susceptibility Health Psychol 24 S78 S84 10.1037/0278-6133.24.4.S78 16045423 (Pubitemid 41099129)
26. B Meiser P Butow A Barratt, et al. 1999 Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer Gynecol Oncol 75 122 129 1:STN:280: DyaK1MvjsVSqtg%3D%3D 10.1006/gyno.1999.5544 10502438 (Pubitemid 29477814)
27. B Meiser P Butow M Friedlander, et al. 2000 Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer J Clin Oncol 18 2250 2257 1:STN:280: DC%2BD3c3ptFaisw%3D%3D 10829045 (Pubitemid 30350217)
28. S van Dijk W Otten MW Zoeteweij, et al. 2003 Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment Br J Cancer 88 1675 1681 10.1038/sj.bjc.6600988 12771979 (Pubitemid 36760408)
29. JR Botkin KR Smith RT Croyle, et al. 2003 Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing Am J Med Genet A 118A 201 209 10.1002/ajmg.a.10102 12673648
30. BN Peshkin MD Schwartz C Isaacs, et al. 2002 Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing Cancer Epidemiol Biomarkers Prev 11 1115 1118 12376518
31. AK Arrington SL Jarosek BA Virnig, et al. 2009 Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer Ann Surg Oncol 16 2697 2704 10.1245/s10434-009-0641-z 19653045
32. NB Jones J Wilson L Kotur, et al. 2009 Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution Ann Surg Oncol 16 2691 2696 10.1245/s10434-009-0547-9 19506956
33. KP McGuire AA Santillan P Kaur, et al. 2009 Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients Ann Surg Oncol 16 2682 2690 10.1245/s10434-009-0635-x 19653046
34. P Sheeran 2002 Intention-behavior relations: a conceptual and empirical review Eur Rev Soc Psychol 12 1 36 10.1080/14792772143000003
35. M Fishbein M Hennessy M Kamb, et al. 2001 Using intervention theory to model factors influencing behavior change. Project RESPECT Eval Health Prof 24 363 384 1:STN:280:DC%2BD38%2FovVOnsQ%3D%3D 10.1177/01632780122034966 11817197 (Pubitemid 33121522)
36. D Morgan H Sylvester FL Lucas, et al. 2009 Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting Fam Cancer 8 277 287 1:CAS:528:DC%2BD1MXhtlKhtL%2FK 10.1007/s10689-009-9242-z 19347608